ArticleJAMA health forum2022

Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017.

Patricia Mae G Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.